Dependence of metastatic cancer cell invasion on MLCK-catalyzed phosphorylation of myosin regulatory light chain

Prostate Cancer and Prostatic Diseases

Volumn 6, Issue 3, 2003, Pages 212-216

  Tohtong, R ^a   Phattarasakul, K ^a   Jiraviriyakul, A ^a   Sutthiphongchai, T ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Cancer invasion; Myosin light chain kinase; Myosin regulatory light chain; Phosphorylation

Indexed keywords

GELATINASE; MYOSIN LIGHT CHAIN; MYOSIN LIGHT CHAIN KINASE; MYOSIN LIGHT CHAIN KINASE INHIBITOR;

ANIMAL CELL; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL ADHESION; CELL INVASION; CELL MOTILITY; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME MECHANISM; EXTRACELLULAR MATRIX; IN VITRO STUDY; INHIBITION KINETICS; METASTASIS; METASTASIS POTENTIAL; NONHUMAN; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; RAT; REGULATORY MECHANISM;

ADENOCARCINOMA; ANIMALS; AZEPINES; CELL DIVISION; CELL LINE, TUMOR; CELL MOVEMENT; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; METHOTREXATE; MYOSIN LIGHT CHAINS; MYOSIN-LIGHT-CHAIN KINASE; NAPHTHALENES; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PHOSPHORYLATION; PROSTATIC NEOPLASMS; RATS;

EID: 0141613922     PISSN: 13657852     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.pcan.4500663     Document Type: Article

References (25)

1. Meyer T, Hart IR. Mechanisms of tumor metastasis. Eur J Cancer 1998; 34: 214-221.
2. Spudich JA. In persuit of myosin function. Cell Regul 1989; 1: 1-11.
3. Somlyo AP, Somlyo AV. Signal transduction by G-proteins. Rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. J Physiol 2000; 522: 177-185.
4. Tan JL, Ravid S, Spudich JA. Control of nonmuscle myosins by phosphorylation. Annu Rev Biochem 1992; 61: 721-759.
5. Quax PHA et al. Plasminogen activator and matrix metalloproteinase production and extracellular matrix degradation by rat prostate cancer cells in vitro: correlation with metastatic behaviour in vivo. Prostate 1997; 32: 196-204.
6. Gillespie GY et al. Glioma migration can be blocked by nontoxic inhibitors of myosin II. Cancer Res 1999; 59: 2076-2082.
7. Klemke RL et al. Regulation of cell motility by mitogen-activated protein kinase. J Cell Biol 1997; 137: 481-492.
8. Yoshioka K et al. Small GTP-binding protein Rho stimulates the actomyosin system, leading to invasion of tumor cells. J Biol Chem 1998; 273: 5146-5154.
9. Itoh K et al. An essential part for Rho-associated kinase in the transcellular invasion of tumor cells. Nat Med 1999; 5: 221-225.
10. Nguyen DHD et al. Myosin light chain kinase functions downstream of Ras/ERK to promote migration of urokinase-type plasminogen activator-stimulated cells in an integrin-selective manner. J Cell Biol 1999; 146: 149-164.
11. Cooper CR et al. Adhesion and invasion potential of rat prostatic cancer cells: correlation with metastatic potential. Invasion Metast 1993; 13: 178-184.
12. Saitoh J et al. Selective inhibition of catalytic activity of smooth muscle myosin light chain kinase. J Biol Chem 1987; 262: 7796-7801.
13. Amano M et al. Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J Biol Chem 1996; 271: 20246-20249.
14. Bresnick AR. Molecular mechanisms of nonmuscle myosin-II regulation. Curr Opin Cell Biol 1999; 11: 26-33.
15. 2+-independent contraction of smooth muscle. J Biol Chem 1998; 273: 23433-23439.
16. Komatsu S et al. Identification of MAPKAPK homolog (MAPAPK-4) as a myosin II regulatory light chain kinase in sea urchin egg extracts. Arch Biochem Biophys 1997; 343: 55-62.
17. Isemura M et al. Myosin light chain kinase inhibitors ML-7 and ML-9 inhibit mouse lung carcinoma cell attachment to the fibronectin substratum. Cell Biol Int Rep 1991; 15: 965-972.
18. Brenner W et al. Differential inhibition of renal cancer cell invasion mediated by fibronectin, collagen IV and laminin. Cancer Lett 2000; 155: 199-205.
19. Boxberger H-J, Paweletz N. Influences of various substrata on morphology, motility and invasiveness of rat tumour cells. II. Studies on the highly metastatic variants BSp 73 ASML. Anticancer Res 1990; 10: 1265-1274.
20. Mohler JL, Levy F, Sharief Y. Metastatic potential and substrate dependence of cell motility and attachment in the Dunning R3327 rat prostatic adenocarcinoma model. Cancer Res 1991; 51: 6580-6585.
21. 2+/calmodulin-dependent protein kinases in insulin release from the rat pancreatic β cell. Biochem Biophys Res Commun 1993; 191: 255-261.
22. Choi OH, Adelstein RS, Beaven MA. Secretion from rat basophilic RBL-2H3 cells is associated with diphosphorylation of myosin light chains by myosin light chain kinase as well as phosphorylation by protein kinase C. J Biol Chem 1994; 269: 536-541.
23. −secretion in intestinal epithelial. Am J Physiol 1999; 277(Part 1): 441-447.
24. Belotti D et al. Paclitaxel (Taxol(R)) inhibits motility of paclitaxel-resistant human ovarian carcinoma cells. Clin Cancer Res 1996; 2: 1725-1730.
25. Terzis AJA et al. Proliferation, migration and invasion of human glioma cells exposed to antifolate drugs. Int J Cancer 1993; 54: 112-118.